Opportunity
SAM #75F40126Q134622
FDA NCTR Solicits Next Generation Sequencing System (MiSeq i100 or Equivalent) with Multi-Year Service Options
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
July 28, 2026
Respond By
August 05, 2026
Identifier
75F40126Q134622
NAICS
334516
The FDA's National Center for Toxicological Research (NCTR) is seeking to procure a Next Generation Sequencing (NGS) System for microbiology surveillance and pathogen identification in laboratory animals and biological samples. - Government Buyer: - U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Contracting Officer: Nick Sartain - OEMs and Vendors: - Illumina (MiSeq i100 referenced as the benchmark system) - Products/Services Requested: - One (1) Next Generation Sequencing System (new MiSeq i100 or equivalent) - Must deliver up to 25 Gigabytes output, 25 million reads per run, read length up to 500 bases - Embedded touchscreen and on-instrument computer - Hardware-accelerated Dragen Bio-IT secondary analysis pipelines - Includes 12-month parts and labor warranty with on-site service - Optional post-warranty service agreements for up to three years - Scheduled on-site preventive maintenance - Unlimited on-site corrective maintenance and repairs within 3 business days - Unlimited software and firmware updates - Technical support Monday through Friday (excluding Federal Holidays) - Unique/Notable Requirements: - System must be new (not refurbished) and meet or exceed MiSeq i100 specifications - Delivery required within 100 days of contract award - On-site maintenance and support at NCTR - Option for up to three years of post-warranty service
Description
See attached combined synopsis/solicitation.